Kelly M. Malloy

Papers

Total Citations

255

H-Index

About

Dr. Kelly M. Malloy is a leading otolaryngologist and head and neck surgeon whose research has significantly advanced the field of transoral robotic surgery (TORS) for oropharyngeal cancer. Her landmark 2012 prospective study, cited over 228 times, demonstrated that TORS alone—without adjuvant chemotherapy or radiation—could achieve excellent local control in carefully selected patients with oropharyngeal squamous cell carcinoma. This work fundamentally challenged the prevailing paradigm of multimodality treatment, offering a paradigm shift toward de-escalation and reduced treatment morbidity. Dr. Malloy’s expertise in surgical complications is equally impactful; her 2020 analysis of TORS complications provides essential safety data that guides modern surgical practice. Her contributions have helped establish TORS as a standard-of-care option, improving functional outcomes and quality of life for thousands of patients. Dr. Malloy’s research continues to shape clinical guidelines and inspire a new generation of head and neck surgeons to pursue minimally invasive, organ-preserving approaches.